Recent studies have shown that spatial navigation deficits are more typical and prominent in aMCI individuals with positive compared to those with negative AD biomarkers22,23,27 and are associated with higher levels of AD pathology as measured by amyloid-β and phosphorylated tau (p-tau) in CSF.21 Here, MAPT is linked to Alzheimer disease.